Clinical Trial Update: Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating adding lomustine to standard temozolomide and radiation for newly diagnosed MGMT-methylated glioblastoma; study status is active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Lomustine (Gleostine) (lomustine)
• Temozolomide (Temozolomide)

Snippet

Sponsor: NRG Oncology | Conditions: Glioblastoma, Gliosarcoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING